These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 19069147)
21. Case 6: maintenance therapy for simple intermittent gout. Edwards NL Am J Med; 2006 Nov; 119(11 Suppl 1):S20-2. PubMed ID: 17059908 [No Abstract] [Full Text] [Related]
22. New-onset diabetes after transplantation: a threat to graft and patient survival. Krentz AJ; Wheeler DC Lancet; 2005 Feb 19-25; 365(9460):640-2. PubMed ID: 15721460 [No Abstract] [Full Text] [Related]
23. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. Sjöström L; Lindroos AK; Peltonen M; Torgerson J; Bouchard C; Carlsson B; Dahlgren S; Larsson B; Narbro K; Sjöström CD; Sullivan M; Wedel H; N Engl J Med; 2004 Dec; 351(26):2683-93. PubMed ID: 15616203 [TBL] [Abstract][Full Text] [Related]
24. Understanding hyperuricemia: nursing implications. Johnson ES Nurs Clin North Am; 1972 Jun; 7(2):399-406. PubMed ID: 4482424 [No Abstract] [Full Text] [Related]
25. Post-transplant diabetes mellitus and renal function with tacrolimus: A decade of use, a decade of evidence. Foreword. Vanrenterghem Y Nephrol Dial Transplant; 2004 Dec; 19 Suppl 6():vi1-vi2. PubMed ID: 15575020 [No Abstract] [Full Text] [Related]
26. Risk for posttransplant diabetes mellitus with current immunosuppressive medications. Hjelmesaeth J; Hartmann A Am J Kidney Dis; 2000 Mar; 35(3):562. PubMed ID: 10692289 [No Abstract] [Full Text] [Related]
27. Cyclosporine-induced hyperuricemia and gout in renal transplants. Ben Hmida M; Hachicha J; Bahloul Z; Kaddour N; Kharrat M; Jarraya F; Jarraya A Transplant Proc; 1995 Oct; 27(5):2722-4. PubMed ID: 7482890 [No Abstract] [Full Text] [Related]
28. [Establishment of therapeutic goal and plan of gout and asymptomatic hyperuricemia]. Fujimori S Nihon Rinsho; 2008 Apr; 66(4):729-35. PubMed ID: 18409523 [TBL] [Abstract][Full Text] [Related]
29. [Idiopathic hyperuricemia with overproduction of uric acid]. Mizuta E; Igawa O; Hisatome I Nihon Rinsho; 2008 Apr; 66(4):675-8. PubMed ID: 18409513 [TBL] [Abstract][Full Text] [Related]
30. Hyperuricemia in kidney transplant recipients with intact graft function. Kim KM; Kim SS; Han DJ; Yang WS; Park JS; Park SK Transplant Proc; 2010 Nov; 42(9):3562-7. PubMed ID: 21094816 [TBL] [Abstract][Full Text] [Related]
31. [Over-weight as risk factor with special regard to hypertension, arteriosclerosis and gout]. Schollmeyer P Z Allgemeinmed; 1972 Oct; 48(29):1342-5. PubMed ID: 4636977 [No Abstract] [Full Text] [Related]
32. Long-term (24-month) follow-up of steroid withdrawal in renal allograft recipients with posttransplant diabetes mellitus. Fabrega AJ; Meslar P; Cohan J; Lash J; Pollak R Transplantation; 1995 Dec; 60(12):1612-4. PubMed ID: 8545899 [No Abstract] [Full Text] [Related]
33. Management of the kidney transplant recipient. Padiyar A; Akoum FH; Hricik DE Prim Care; 2008 Sep; 35(3):433-50, v. PubMed ID: 18710663 [TBL] [Abstract][Full Text] [Related]
34. New-onset diabetes mellitus after solid organ transplantation. Bodziak KA; Hricik DE Transpl Int; 2009 May; 22(5):519-30. PubMed ID: 19040489 [TBL] [Abstract][Full Text] [Related]
35. Risk profile for cardiovascular morbidity and mortality after lung transplantation. De Vito Dabbs A; Song MK Nurs Clin North Am; 2008 Mar; 43(1):37-53; vi. PubMed ID: 18249224 [TBL] [Abstract][Full Text] [Related]
36. Gout in renal allograft recipients according to the pretransplant hyperuricemic status. Hernández-Molina G; Cachafeiro-Vilar A; Villa AR; Alberú J; Rull-Gabayet M Transplantation; 2008 Dec; 86(11):1543-7. PubMed ID: 19077887 [TBL] [Abstract][Full Text] [Related]